Prostate Cancer Research partners with Our Future Health

Prostate cancer is the most common cancer in men in the UK with over 50,000 men diagnosed each year in the UK. 1 in 4 Black men, 1 in 8 White men and 1 in 13 men of other ethnicities will be affected by this disease in their lifetime.

Prostate Cancer Research (PCR) is committed to developing and delivering breakthrough medicines and treatments, and working towards a more equitable world future where all people are free from the impact of prostate cancer.

PCR are excited to announce that it has partnered with Our Future Health as an Affiliate Charity. Our Future Health is an ambitious collaboration between the public, charity and private sectors to build the UK’s largest health research programme – bringing people together to develop new ways to prevent, detect and treat disease.

Together, we hope to be able to make a real difference to the lives of so many men affected by this disease, and their loved ones, families and friends who also bear the brunt of this awful disease.

“

We’re delighted to be working with Prostate Cancer Research as an affiliate charity of Our Future Health. Their expertise offers an exciting opportunity for us to work together to make discoveries that can prevent these diseases and help those affected by them.”
Dr Raghib Ali
Chief Executive and Chief Medical Officer of Our Future Health,

“

We are excited to be partnering with Our Future Health as an Affiliate Charity. At Prostate Cancer Research we understand the importance of research to help improve the lives of people affected by this disease now and those who will sadly be affected in the future. We are supporting Our Future Health so that this research delivers real and lasting change for the men who need it most.”
David James
Director of Patient Projects at Prostate Cancer Research